In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the healthcare system “needs to function better.”

UnitedHealth Group CEO Andrew Witty told analysts that the company is positioned well for growth in 2025. This comes just a month after the CEO of its insurance unit was murdered.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements that critics have been seeking.

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less costly" during the company's first earnings call since the murder of Brian Thompson,

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 billion, continues to navigate a complex landscape of opportunities and challenges as it maintains its position as a dominant force in the healthcare industry.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies for high costsIn his first public remarks since the murder of

Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In 2024, the US economy was stronger than expected;

UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization surprised Wall Street.

UnitedHealth shares tumbled Thursday after the health insurer reported fourth-quarter results below Wall Street’s expectations and issued a lackluster outlook. Monitor these key post-earnings price levels.